Pill vs. insulin: new hope for kidney transplant patients with diabetes?
NCT ID NCT05702931
Summary
This study is testing if a daily pill called semaglutide (Rybelsus) is a safe and effective way to control high blood sugar in people who have recently received a kidney transplant. It will compare the pill to a placebo (dummy pill) in 104 patients, with both groups also receiving standard care. The main goal is to see if the pill controls blood sugar as well as current treatments, while also checking if it helps patients use less insulin, lose weight, and avoid low blood sugar episodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department og Nephrology and Endocrinology, Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.